Ologen implant versus mitomycin C for trabeculectomy: a systematic review and meta-analysis

M He, W Wang, X Zhang, W Huang - PLoS One, 2014 - journals.plos.org
Objective To evaluate the application of the Ologen implant compared to mitomycin C
(MMC) on the outcome of trabeculectomy and to examine the balance of risks and benefits …

Device‐modified trabeculectomy for glaucoma

X Wang, R Khan, A Coleman - Cochrane Database of …, 2015 - cochranelibrary.com
Background Glaucoma is an optic neuropathy that leads to vision loss and blindness. It is
the second most common cause of irreversible blindness worldwide. The main treatment for …

Biocompatibility of a fish scale-derived artificial cornea: cytotoxicity, cellular adhesion and phenotype, and in vivo immunogenicity

TH Van Essen, L Van Zijl, T Possemiers, AA Mulder… - Biomaterials, 2016 - Elsevier
Purpose To determine whether a fish scale-derived collagen matrix (FSCM) meets the basic
criteria to serve as an artificial cornea, as determined with in vitro and in vivo tests. Methods …

Subscleral trabeculectomy with mitomycin-C versus ologen for treatment of glaucoma

HM Marey, SS Mandour, AF Ellakwa - Journal of Ocular …, 2013 - liebertpub.com
Purpose: To compare the results of subscleral trabeculectomy (SST) augmented with
mitomycin-C (MMC) versus Ologen™ implant regarding intraocular pressure (IOP) control …

[PDF][PDF] Glaucoma-A Eye Disorder Its Causes, Risk Factor, Prevention and Medication.

D Bhowmik, KPS Kumar, L Deb, S Paswan… - The Pharma …, 2012 - Citeseer
Accepted for publication 23.02. 2012. Glaucoma refers to a group of eye conditions that lead
to damage to the optic nerve, the nerve that carries visual information from the eye to the …

A Comparative Study: The Use of Collagen Implant versus Mitomycin‐C in Combined Trabeculotomy and Trabeculectomy for Treatment of Primary Congenital …

AAS Singab, OA Mohammed… - Journal of …, 2017 - Wiley Online Library
Purpose. To compare Ologen implant versus mitomycin‐C (MMC) in combined
trabeculotomy and trabeculectomy as a treatment of primary congenital glaucoma. Setting …

Outcomes of bleb revision with ologen following filtering glaucoma surgery

HL Kornmann, RL Fellman, OU Smith… - European Journal …, 2022 - journals.sagepub.com
Purpose This study reports long-term outcomes of bleb revision with ologen™ Collagen
Matrix (Aeon Astron Europe BV, the Netherlands) for the surgical management of various …

Subscleral trabeculectomy with Ologen implant versus mitomycin C in primary infantile glaucoma

RR Kassem, AF Esmael - Saudi Journal of Ophthalmology, 2024 - journals.lww.com
PURPOSE: The purpose of this study is to compare the effect of subscleral trabeculectomy
(SST) augmented with mitomycin C (MMC) versus Ologen implant as secondary procedures …

Subscleral Trabeculectomy with Ologen implant versus Mitomycin C in primary infantile glaucoma: up to 103 months' follow-up

RR Kassem, AF Esmael - 2023 - researchsquare.com
Purpose To compare the effect of SST augmented with Mitomycin C (MMC) versus Ologen
implant as secondary procedures for treatment of primary congenital glaucoma. Methods …

[HTML][HTML] Collagen matrix implantation following pterygium excision: outcomes of a preliminary tested hypothesis

M Arish, AN Nadjafi, M Jahangard - Medical Hypothesis, Discovery …, 2013 - ncbi.nlm.nih.gov
This study was conducted to evaluate the effect of collagen matrix implant on pterygium
recurrence compared with a control group following pterygium removal surgery. Following …